We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+26%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$419B
AUM Growth
+$49.9B
Cap. Flow
-$5.75B
Cap. Flow %
-1.37%
Top 10 Hldgs %
30.74%
Holding
3,870
New
648
Increased
1,897
Reduced
998
Closed
136

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$2.07B
2
MSFT icon
Microsoft
MSFT
+$1.51B
3
NVDA icon
NVIDIA
NVDA
+$1.18B
4
AAPL icon
Apple
AAPL
+$1.04B
5
AVGO icon
Broadcom
AVGO
+$949M

Sector Composition

Rank Sector Weight
1 Technology 35.08%
2 Financials 10.73%
3 Industrials 10.29%
4 Consumer Discretionary 9.57%
5 Healthcare 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRVS icon
2451
Corvus Pharmaceuticals
CRVS
$1.09B
$2.42M ﹤0.01%
161,821
+12,695
+9% +$176K
BDN
2452
Brandywine Realty Trust
BDN
$511M
$2.42M ﹤0.01%
762,333
+64,000
+9% +$192K
SLDB icon
2453
Solid Biosciences
SLDB
$973M
$2.41M ﹤0.01%
241,642
-158,650
-40% -$1.2M
PMT
2454
PennyMac Mortgage Investment
PMT
$800M
$2.41M ﹤0.01%
213,825
-309,741
-59% -$3.41M
ESRT icon
2455
Empire State Realty Trust
ESRT
$734M
$2.41M ﹤0.01%
445,624
-476,274
-52% -$2.59M
KIM.PRN icon
2456
Kimco Realty Corp 7.25% Class N Preferred Stock
KIM.PRN
$83.8M
$2.41M ﹤0.01%
39,354
-86
-0.2% -$5.28K
OVID icon
2457
Ovid Therapeutics
OVID
$514M
$2.4M ﹤0.01%
+893,254
New +$2.3M
BFST icon
2458
Business First Bancshares
BFST
$1.02B
$2.4M ﹤0.01%
78,000
+18,360
+31% +$519K
ABUS icon
2459
Arbutus Biopharma
ABUS
$1.01B
$2.38M ﹤0.01%
496,609
+237,592
+92% +$1.04M
ZVRA icon
2460
Zevra Therapeutics
ZVRA
$716M
$2.38M ﹤0.01%
166,171
-26,417
-14% -$294K
SLYG icon
2461
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.88B
$2.38M ﹤0.01%
+19,997
New +$2.16M
SXC icon
2462
SunCoke Energy
SXC
$860M
$2.38M ﹤0.01%
295,258
+114,324
+63% +$883K
AMCX icon
2463
AMC Global Media
AMCX
$498M
$2.38M ﹤0.01%
237,979
+171,138
+256% +$1.52M
PCRX icon
2464
Pacira BioSciences
PCRX
$1B
$2.37M ﹤0.01%
93,513
+3,707
+4% +$87.6K
ALOY
2465
REalloys Inc
ALOY
$610M
$2.37M ﹤0.01%
+164,034
New +$1.87M
TNDM icon
2466
Tandem Diabetes Care
TNDM
$1.27B
$2.37M ﹤0.01%
157,066
-206,736
-57% -$3.61M
HBNC icon
2467
Horizon Bancorp
HBNC
$1.01B
$2.37M ﹤0.01%
118,578
+12,399
+12% +$228K
CCOI icon
2468
Cogent Communications
CCOI
$466M
$2.36M ﹤0.01%
169,874
+1,374
+0.8% +$25.3K
DMC
2469
Del Monte Corp
DMC
$1.51B
$2.36M ﹤0.01%
84,450
+3,757
+5% +$132K
COTY icon
2470
Coty
COTY
$2.32B
$2.35M ﹤0.01%
1,087,044
+459,259
+73% +$991K
TENX icon
2471
Tenax Therapeutics
TENX
$73M
$2.35M ﹤0.01%
+161,187
New +$2.06M
VO icon
2472
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$2.34M ﹤0.01%
+29,100
New +$2.26M
MAZE
2473
Maze Therapeutics
MAZE
$1.38B
$2.34M ﹤0.01%
78,468
+15,108
+24% +$396K
AVDV icon
2474
Avantis International Small Cap Value ETF
AVDV
$20.2B
$2.34M ﹤0.01%
+22,705
New +$2.42M
CBNK icon
2475
Capital Bancorp
CBNK
$592M
$2.34M ﹤0.01%
66,563
+2,915
+5% +$93.4K

Similar funds

Nuveen's Q2 2026 Portfolio in Review

As of Q2 2026, Nuveen held 3,870 positions worth $419B, up 14% from $369B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Nuveen's Q2 2026 filing shows 648 new, 1,897 increased, 998 reduced and 136 closed positions. Its largest new stake was Honeywell Aerospace: 2,688,848 shares worth $594M. The largest sale was Amazon, an estimated $2.07B.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • Nuveen's largest Q2 2026 buy was Honeywell Aerospace: 2,688,848 shares worth $594M.
  • Nuveen added most to Tesla in Q2 2026, an estimated $944M increase.
  • Nuveen's biggest Q2 2026 reduction was Amazon, cutting an estimated $2.07B.
  • Nuveen fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2026, selling an estimated $393M.
  • Nuveen's ten largest holdings make up 31% of its $419B portfolio in Q2 2026.
  • Nuveen opened 648 new positions and closed 136 in Q2 2026.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $419B.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.